Journal Watch · Frontiers in Immunology · 2026

Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina.

Higher κ-FLC index thresholds may improve diagnostic specificity in real-world clinical settings and should be validated in independent series.

Manin A, Ingenito F, Cores EV et al.Frontiers in Immunology4 min readPharma relevance 55/100

DOI: 10.3389/fimmu.2026.1803446PMID: 42292422Study type: cohort / observational clinical study

TL;DR

Higher κ-FLC index thresholds may improve diagnostic specificity in real-world clinical settings and should be validated in independent series.

Key findings

  • In the primary comparison between MS/CIS and OIND, the optimal κ-FLC index cut-off was 14.6, yielding a sensitivity of 73.5% and a specificity of 68.1%.
  • The lower threshold of 6.1 showed higher sensitivity (85.7%) but limited specificity (35.4%), while Reiber's diagram for κ-FLC showed the highest sensitivity (91.8%) but lower specificity (45.8%).<h4>Conclusions</h4>The κ-FLC index is a valuable quantitative biomarker of intrathecal immunoglobulin synthesis in MS.
  • In our setting, a higher κ-FLC index threshold provided a more balanced diagnostic profile, whereas Reiber's diagram favored sensitivity.
  • Higher κ-FLC index thresholds may improve diagnostic specificity in real-world clinical settings and should be validated in independent series.

Numbers at a glance (from the abstract)

73.5%68.1%85.7%35.4%91.8%45.8%p < 0.001

Every figure above is taken verbatim from the abstract below. Check the full text for denominators, confidence intervals and subgroup detail.

What they did

In addition, intrathecal κ-FLC synthesis was assessed using the hyperbolic Reiber diagram (Reiber's diagram). Diagnostic performance was assessed using receiver operating characteristic (ROC) curves, with cut-off values derived from Youden's index and compared with previously proposed thresholds.<h4>Results</h4>A total of 124 patients were included (49 MS/CIS, 48 OIND, 27 NIND). Median κ-FLC index values were significantly higher in MS/CIS compared with OIND and NIND (p < 0.001).

Full abstract (original)

Background: <h4>Background</h4>Intrathecal immunoglobulin synthesis is a hallmark of multiple sclerosis (MS) and can be assessed using the kappa free light chain (κ-FLC) index. Although widely adopted, the optimal diagnostic cut-off of the κ-FLC index may vary according to the clinical context and comparison group.<h4>Objective</h4>To evaluate the diagnostic performance of the κ-FLC index for MS in a real-world series including inflammatory and non-inflammatory neurological disorders.<h4>Methods</h4>We conducted a retrospective cross-sectional study including consecutive patients aged ≥16 years undergoing diagnostic lumbar puncture at a tertiary public hospital in Argentina. Patients were classified as MS/clinically isolated syndrome (MS/CIS), other inflammatory neurological diseases (OIND), or non-inflammatory neurological diseases (NIND). κ-FLC, IgG, and albumin were measured in paired cerebrospinal fluid and serum samples, and κ-FLC index was calculated using quotient-based normalization.

What they did: In addition, intrathecal κ-FLC synthesis was assessed using the hyperbolic Reiber diagram (Reiber's diagram). Diagnostic performance was assessed using receiver operating characteristic (ROC) curves, with cut-off values derived from Youden's index and compared with previously proposed thresholds.<h4>Results</h4>A total of 124 patients were included (49 MS/CIS, 48 OIND, 27 NIND). Median κ-FLC index values were significantly higher in MS/CIS compared with OIND and NIND (p < 0.001).

Results & conclusions: In the primary comparison between MS/CIS and OIND, the optimal κ-FLC index cut-off was 14.6, yielding a sensitivity of 73.5% and a specificity of 68.1%. The lower threshold of 6.1 showed higher sensitivity (85.7%) but limited specificity (35.4%), while Reiber's diagram for κ-FLC showed the highest sensitivity (91.8%) but lower specificity (45.8%).<h4>Conclusions</h4>The κ-FLC index is a valuable quantitative biomarker of intrathecal immunoglobulin synthesis in MS. In our setting, a higher κ-FLC index threshold provided a more balanced diagnostic profile, whereas Reiber's diagram favored sensitivity. Higher κ-FLC index thresholds may improve diagnostic specificity in real-world clinical settings and should be validated in independent series.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1803446 · PubMed 42292422.

Why it matters for pharma & biotech

  • Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
  • Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.

Frequently asked questions

What did this Frontiers in Immunology study find?

Higher κ-FLC index thresholds may improve diagnostic specificity in real-world clinical settings and should be validated in independent series.

What type of study is this?

It is a cohort / observational clinical study, published in Frontiers in Immunology in 2026. In addition, intrathecal κ-FLC synthesis was assessed using the hyperbolic Reiber diagram (Reiber's diagram).

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1803446. PubMed ID: 42292422. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Manin A, Ingenito F, Cores EV et al.. Kappa free light chain index in multiple sclerosis and other inflammatory CNS diseases: a pilot single-center study from Argentina.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1803446.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/kappa-free-light-chain-index-in-multiple-sclerosis-and-other-inflammator-803446/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides